$TMPOQ
Tempo Automation Holdings, Inc.

2022 Q1 Form 10-Q Financial Statement

#000141057822001463 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $3.652M
YoY Change
Gross Profit $245.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $7.522M
YoY Change
% of Gross Profit 3070.2%
Research & Development $3.329M
YoY Change
% of Gross Profit 1358.78%
Depreciation & Amortization $1.642M
YoY Change
% of Gross Profit 670.2%
Operating Expenses $1.139M $1.250M
YoY Change -8.89%
Operating Profit -$1.139M -$1.253M
YoY Change -9.11%
Interest Expense $7.710K $40.00K
YoY Change -80.73%
% of Operating Profit
Other Income/Expense, Net $80.41K -$10.27M
YoY Change -100.78%
Pretax Income -$1.058M -$11.52M
YoY Change -90.81%
Income Tax
% Of Pretax Income
Net Earnings -$1.058M -$11.52M
YoY Change -90.82%
Net Earnings / Revenue
Basic Earnings Per Share -$1.85
Diluted Earnings Per Share -$60.68K -$400.7K
COMMON SHARES
Basic Shares Outstanding 13.95M
Diluted Shares Outstanding 6.749M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $27.48K
Short-Term Investments
Other Short-Term Assets $109.8K $300.0K
YoY Change -63.4%
Inventory
Prepaid Expenses $109.8K
Receivables
Other Receivables
Total Short-Term Assets $109.8K $300.0K
YoY Change -63.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $82.58M $230.1M
YoY Change -64.11%
Other Assets
YoY Change
Total Long-Term Assets $82.58M $230.2M
YoY Change -64.13%
TOTAL ASSETS
Total Short-Term Assets $109.8K $300.0K
Total Long-Term Assets $82.58M $230.2M
Total Assets $82.69M $230.5M
YoY Change -64.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.750M $1.300M
YoY Change 419.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.569M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.408M $1.300M
YoY Change 546.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.74M $43.90M
YoY Change -52.75%
Total Long-Term Liabilities $20.74M $43.90M
YoY Change -52.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.408M $1.300M
Total Long-Term Liabilities $20.74M $43.90M
Total Liabilities $29.15M $45.20M
YoY Change -35.51%
SHAREHOLDERS EQUITY
Retained Earnings -$28.88M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$28.88M -$44.70M
YoY Change
Total Liabilities & Shareholders Equity $82.69M $230.5M
YoY Change -64.13%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.058M -$11.52M
YoY Change -90.82%
Depreciation, Depletion And Amortization $1.642M
YoY Change
Cash From Operating Activities -$646.7K -$764.9K
YoY Change -15.46%
INVESTING ACTIVITIES
Capital Expenditures $13.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $147.6M
YoY Change
Cash From Investing Activities $147.6M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $200.0K
YoY Change
Cash From Financing Activities -146.9M
YoY Change
NET CHANGE
Cash From Operating Activities -646.7K -764.9K
Cash From Investing Activities 147.6M
Cash From Financing Activities -146.9M
Net Change In Cash -8.390K -764.9K
YoY Change -98.9%
FREE CASH FLOW
Cash From Operating Activities -$646.7K -$764.9K
Capital Expenditures $13.00K
Free Cash Flow -$659.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 acev Redemption Of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination
RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination
P2D
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001813658
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
KY
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q1 acev Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39406
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
ACE Convergence Acquisition Corp.
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1013 Centre Road, Suite 403S
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19805
CY2022Q1 dei City Area Code
CityAreaCode
302
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
633-2102
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 us-gaap Assets Current
AssetsCurrent
121530
CY2022Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
82578288
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230158259
CY2022Q1 us-gaap Assets
Assets
82688080
CY2021Q4 us-gaap Assets
Assets
230279789
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8390
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
109792
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
113140
CY2022Q1 us-gaap Assets Current
AssetsCurrent
109792
CY2022Q1 acev Accrued Liabilities Excluding Offering Costs Current
AccruedLiabilitiesExcludingOfferingCostsCurrent
6749525
CY2021Q4 acev Accrued Liabilities Excluding Offering Costs Current
AccruedLiabilitiesExcludingOfferingCostsCurrent
6260642
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
739980
CY2022Q1 acev Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
88894
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
829294
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
527756
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8407693
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6788398
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
12693389
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
12766082
CY2022Q1 acev Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
8050000
CY2021Q4 acev Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
8050000
CY2022Q1 us-gaap Liabilities
Liabilities
29151082
CY2021Q4 us-gaap Liabilities
Liabilities
27604480
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
82412315
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28875892
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27325266
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-28875317
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-27324691
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82688080
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230279789
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
1138897
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1252982
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1138897
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1252982
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-72693
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10311560
CY2022Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7714
CY2021Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
40113
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
80407
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10271447
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1058490
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11524429
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-27324691
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
492136
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1058490
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-28875317
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-33171194
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11524429
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-44695623
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1058490
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-11524429
CY2022Q1 acev Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
7714
CY2021Q1 acev Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
40114
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-72693
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10311560
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3348
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42839
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
488883
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
445211
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-646666
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-764933
CY2022Q1 acev Cash Deposited In Trust Account
CashDepositedInTrustAccount
492136
CY2022Q1 acev Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption
-148079821
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
147587685
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1130412
CY2022Q1 acev Payments For Redemption Of Ordinary Shares
PaymentsForRedemptionOfOrdinaryShares
148079821
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-146949409
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8390
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-764933
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8390
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
792416
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27483
CY2022Q1 acev Transaction Costs
TransactionCosts
13273096
CY2022Q1 acev Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
4600000
CY2022Q1 acev Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
8050000
CY2022Q1 acev Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
623096
CY2022Q1 acev Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount
0.80
CY2022Q1 acev Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination
ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
0.50
CY2022Q1 acev Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001
CY2022Q1 acev Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent
0.15
CY2022Q1 acev Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2022Q1 acev Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
148079821
CY2022Q1 acev Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2022Q1 acev Maximum Net Interest To Pay Dissolution Expenses
MaximumNetInterestToPayDissolutionExpenses
100000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2022Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
82578288
CY2022Q1 acev Working Capital Deficit
WorkingCapitalDeficit
8297901
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p>
CY2022Q1 acev Amount Deposited In Trust Account
AmountDepositedInTrustAccount
246068
CY2022Q1 acev Amount Deposited In Trust Account
AmountDepositedInTrustAccount
246068
CY2022Q1 acev Amount Deposited In Trust Account
AmountDepositedInTrustAccount
492136
CY2022Q1 acev Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
148079821
CY2021 acev Proceeds From Issuance Of Temporary Equity
ProceedsFromIssuanceOfTemporaryEquity
230000000
CY2021 acev Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
-11270000
CY2021 acev Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
-12737837
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
24007837
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2022Q1 acev Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
-148079821
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
492136
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
82412315
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13273096
CY2022Q1 acev Offering Costs Charged To Temporary Equity And Accreted To Redemption Value
OfferingCostsChargedToTemporaryEquityAndAccretedToRedemptionValue
12605837
CY2022Q1 acev Offering Costs Allocated To Warrant Liability
OfferingCostsAllocatedToWarrantLiability
667259
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q1 acev Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.</p>
CY2022Q1 acev Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
88894
CY2022Q1 acev Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
88894
CY2020Q3 acev Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2022Q1 acev Cash Underwriting Discount Per Unit
CashUnderwritingDiscountPerUnit
0.20
CY2022Q1 acev Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
4600000
CY2022Q1 acev Deferred Fee Per Unit
DeferredFeePerUnit
0.35
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 acev Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
0.20
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0

Files In Submission

Name View Source Status
0001410578-22-001463-index-headers.html Edgar Link pending
0001410578-22-001463-index.html Edgar Link pending
0001410578-22-001463.txt Edgar Link pending
0001410578-22-001463-xbrl.zip Edgar Link pending
acev-20220331.xsd Edgar Link pending
acev-20220331x10q.htm Edgar Link pending
acev-20220331x10q_htm.xml Edgar Link completed
acev-20220331xex31d1.htm Edgar Link pending
acev-20220331xex31d2.htm Edgar Link pending
acev-20220331xex32d1.htm Edgar Link pending
acev-20220331xex32d2.htm Edgar Link pending
acev-20220331_cal.xml Edgar Link unprocessable
acev-20220331_def.xml Edgar Link unprocessable
acev-20220331_lab.xml Edgar Link unprocessable
acev-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending